This clinical report discusses the interplay of various pathologies that may present similar clinical manifestations, with uncertainty about the distinct impact of each one of them. The patient is a 43-year-old young Asian female with no known medical conditions. She was 33 weeks pregnant when she was admitted for an urgent c-section because of preeclampsia with HELLP syndrome. While hospitalized, she complained about the visual field's loss. A comprehensive ophthalmological examination revealed a severe concentric visual field defect along with well-reduced visual acuity and impaired color vision. Her OCT revealed a bilateral serous macular detachment related to pre-eclampsia. A brain MRI revealed a microstroke at the temporo-parieto-occipital junction (TPO), although it did not fully account for the severity of the visual field deficit. Despite the macular pathology being resolved, the visual field remained deeply impacted. A thorough and complete investigation yielded negative results, leaving the cause of the patient's deficit unknown. The patient likely had a normal pressure glaucoma. Additionally, multifactorial bilateral microvascular ischemic neuropathy (caused especially by high myopia) has significantly affected her visual field. Furthermore, it is also probable that the patient had genetic neuropathy. Initial genetic testing was negative; however, due to the high suspicion of a genetic component, a retest was conducted, and the results were not conclusive. This case represents a highly unusual case of a profoundly affected visual field with no apparent identified cause. This is a notable example of the potential interaction of various local and systemic pathologies that can manifest with similar clinical presentations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268793 | PMC |
http://dx.doi.org/10.7759/cureus.63052 | DOI Listing |
Graefes Arch Clin Exp Ophthalmol
January 2025
Experimental Psychology, Faculty of Social Sciences, Helmholtz Institute, Utrecht University, Utrecht, The Netherlands.
Purpose: Assessing the quality of the visual field is important for the diagnosis of ophthalmic and neurological diseases and, consequently, for rehabilitation. Visual field defects (VFDs) are typically assessed using standard automated perimetry (SAP). However, SAP requires participants to understand instructions, maintain fixation and sustained attention, and provide overt responses.
View Article and Find Full Text PDFJ Neurosci
January 2025
Wellcome Centre for Integrative Neuroimaging; Nuffield Department of Clinical Neuroscience, University of Oxford.
Damage to the primary visual cortex (V1) results in visual field deficits on the contralateral side of the world corresponding to the damaged region. Patients with such loss nonetheless show varying residual vision within this apparently blind region, with the neural mechanisms underlying this ability obscured by small study populations. We identified lesions on structural scans from 39 patients (12 female) with hemianopia and occipital lobe damage.
View Article and Find Full Text PDFRetina
January 2025
Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA.
Purpose: To describe an accessible method of structure-function correlation using optical coherence tomography (OCT) and virtual reality perimetry (VRP) for patients with retinal disease and glaucoma and to compare results with those of conventional Humphrey visual fields (HVF).
Methods: Patients with a diagnosis of glaucoma involving the central visual field or macula-involving retinal disease were recruited. Patients underwent ophthalmic examination followed by OCT imaging, HVF, and VRP testing.
Eur J Neurosci
January 2025
Institute of Cognitive Neuroscience, National Central University, Taiwan.
Previous research demonstrated that transcranial alternating current stimulation (tACS) can induce phosphene perception. However, tACS involves rhythmic changes in the electric field and alternating polarity (excitatory vs. inhibitory phases), leaving the precise mechanism behind phosphene perception unclear.
View Article and Find Full Text PDFJ Magn Reson Imaging
February 2025
Department of Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Backgrounds: Anti-vascular endothelial growth factor (VEGF) therapy has been developed and recognized as an effective treatment for hepatocellular carcinoma (HCC). However, there remains a lack of noninvasive methods in precisely evaluating VEGF expression in HCC.
Purpose: To establish a visual noninvasive model based on clinical indicators and MRI features to evaluate VEGF expression in HCC.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!